AdvisorShares Psychedelics ETF (NY:PSIL)

21.85 UNCHANGED

Delayed Quote Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Psychedelics ETF

< Previous 1 2 3 4 5 Next >

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project ↗

December 06, 2022

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and...

Via Benzinga

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More ↗

November 29, 2022

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

Via Benzinga

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗

November 21, 2022

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

Via Benzinga

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗

November 15, 2022

Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

Via Benzinga

Enveric Biosciences Reports Full-Year 2021 Financial Results ↗

April 01, 2022

Via Benzinga

A Comparison Of 5 Psychedelic ETFs And Indices ↗

November 11, 2022

A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector.

Via Talk Markets

Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More ↗

November 07, 2022

Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'

Via Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More ↗

November 01, 2022

15 Global Psychedelics Executives To Keep An Eye On In 2022

Via Benzinga

Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More ↗

October 14, 2022

Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million...

Via Benzinga

7 Psychedelics Stocks to Buy for a Big Drug Boom ↗

August 30, 2022

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

Via InvestorPlace

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX ↗

August 24, 2022

AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF (ARCA:MSOX) will begin trading on August 24th.

Via Benzinga

Psychedelic Drug Patenting: Still Only Scratching The Surface ↗

April 26, 2022

Psychedelic drug R&D remains in its infancy, with dozens of psychedelics and several

Via Talk Markets

Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity? ↗

April 04, 2022

Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...

Via Benzinga

2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around? ↗

December 30, 2021

Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous opportunity for inv...

Via Benzinga

The Year In Review For Psychedelic Drug Stocks: 2021 ↗

December 21, 2021

2021 was two different

Via Talk Markets

3 Psychedelic Stocks for Potential Out-of-This-World Gains ↗

November 18, 2021

Psychedelic drugs could be a major game-changer when it comes to treating mental illness. All as psilocybin, LSD, and MDMA show progress.

Via InvestorPlace

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio? ↗

September 21, 2021

We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.

Via Talk Markets

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial ↗

September 20, 2021

AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares

Via Benzinga

Which Psychedelic Stock ETF Is Right For You? ↗

September 18, 2021

This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.

Via Talk Markets

Want Quick Exposure To The Psychedelics Sector? Check Out This New Active ETF ↗

September 17, 2021

Retail investors are getting new tools for gaining exposure to the

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.